US Patent Issued to ODYSSEUS BIO on Aug. 11 for "Attenuated Salmonella gallinarum expressing FliC or FliC-hIL2 and uses thereof" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,685, issued on Aug. 11, was assigned to ODYSSEUS BIO Co. LTD. (Jeollanam-do, South Korea).

"Attenuated Salmonella gallinarum expressing FliC or FliC-hIL2 and uses thereof" was invented by Kwangsoo Kim (Gwangju, South Korea), Jong-eun Lee (Seoul, South Korea) and Sol Choy (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are attenuated Salmonella gallinarum expressing FliC (flagellin) or FliC-hIL2 (human IL2 fused to FliC) and use thereof, wherein the Salmonella strain exhibits excellent immune activation ability and anticancer efficacy and thus can be used as a cancer therapeutic agent, together with or independently from ...